Trials / Unknown
UnknownNCT03998956
High-density Mapping-guided bOx Isolation and subsTrate Ablation
Study of High-density Mapping-guided bOx Isolation and subsTrate Ablation for Persistent Atrial Fibrillation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- The Third Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy of high-density mapping guided atrial substrate ablation for persistent atrial fibrillation. 1/5 of the patients with persistent atrial fibrillation undergo pulmonary veins isolation, 2/5 of them pulmonary veins and box isolation while others undergo atrial substrate ablation apart from pulmonary veins and box isolation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CPVI | Circumferential PV isolation only |
| PROCEDURE | CPVI+BOX | Circumferential PV and BOX isolation |
| PROCEDURE | CPVI+BOX+SUB | Atrial substrate ablation apart from circumferential PV and BOX isolation |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2021-08-31
- Completion
- 2021-08-31
- First posted
- 2019-06-26
- Last updated
- 2019-07-01
Source: ClinicalTrials.gov record NCT03998956. Inclusion in this directory is not an endorsement.